SANDRA KELLEY: Open Payments
NPI 1699519660 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,470 in 58 payments from 29 companies in 2025. Trend: 2023 $0 · 2024 $371 · 2025 $1,470
Food & beverage: $1,278Education: $192
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $220 |
| Incyte Corporation | 4 | $181 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| Genentech USA, Inc. | 5 | $99 |
| AstraZeneca Pharmaceuticals LP | 4 | $96 |
| Celgene Corporation | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| Ipsen Biopharmaceuticals, Inc | 2 | $63 |
| GENZYME CORPORATION | 2 | $52 |
| Daiichi Sankyo Inc. | 2 | $51 |
Products named: ERLEADA, REBLOZYL, TAGRISSO, Onivyde, JAKAFI, Fabhalta, Enhertu, QINLOCK.
Industry payments across TN — which companies pay providers there.
